Skip to main content
Clinical Trials/JPRN-jRCTb032190218
JPRN-jRCTb032190218
Completed
Phase 2

Intra-articular injections of platelet-rich plasma for the treatment of osteoarthritis of the knee: a randomized, double-blind, placebo-controlled phase 2 clinical trial. - PRP treatment for osteoarthritis of the knee.

Yamazaki Masashi0 sites30 target enrollmentFebruary 19, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
osteoarthritis of the knee
Sponsor
Yamazaki Masashi
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamazaki Masashi

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who meet the diagnostic criteria for osteoarthritis of the knee
  • 2\. Male and female between 20 years old more and less than 80 years old at the time of informed consent
  • 3\. With a history of chronic (for at least 3 months) knee joint pain more than 35\-mm on 0\- to 100\-mm visual analogue scale
  • 4\. Radiographically documented grades 1\-3 osteoarthritis of the knee, grade according to the Kellgren\-Lawrence radiographic classification scale
  • 5\. With hydrarthrosis or bone marrow lesion or synovitis
  • 6\. Requiring infiltration in monolateral knee
  • 7\. Possibility for observation during follow\-up period of 24 weeks

Exclusion Criteria

  • 1\. BMI less than 18\.5
  • 2\. BMI more than 30
  • 3\. Suffering from polyarticular disease
  • 4\. Valgus knee and varus knee more than 10 degree in X\-ray
  • 5\. Previous knee arthroscopy within 6 months
  • 6\. HA or steroid intra\-articular infiltration within last 1 month
  • 7\. Past history of infectious disease
  • 8\. Skin disease in knee
  • 9\. Compromised host
  • 10\. Systemic autoimmune disease

Outcomes

Primary Outcomes

Not specified

Similar Trials